60 distributed-computing-"Multiple" Postdoctoral positions at The Ohio State University
Sort by
Refine Your Search
-
references, and one or more writing samples (published or in press). Materials should be attached to the application and sent electronically to Dr. Raeshan Davis, Research Scientist and HHMI Program Manager
-
provided by the Ohio Eminent Scholars program. This is a term position for an initial period of one year with the possibility of renewal based on performance and availability of funding. For inquiries
-
| Computer Science and Engineering We are seeking a postdoctoral researcher to work on problems at the intersection of algebraic coding theory, matroid theory, and pseudorandomness/derandomization. The focus
-
| School Biomed Sci - Biomedical Informatics Post Doctoral Researcher to pursue specialized research training and experience under the guidance of a scientific mentor in the Department of Biomedical
-
program of independent research with the primary goal of improving the algorithm codes used to characterize the Earth’s gravitational field. Duties will include specialized scientific/numerical analysis
-
Public Health, Epidemiology, Nutrition, Physiology or related program required; strong computer skills preferred; Requires successful completion of a background check. Qualified candidates may be asked
-
engineering related research, makes and records observations and measurements, collects and compiles data for computer input and analysis, perform literature search on related topics, and operates and maintains
-
laboratory conditions. Must be able to work at a computer for extended periods for data analysis, molecular modeling, and manuscript preparation. May require occasional work with biological samples, including
-
-employment physical including a drug screen. Additional Information: The focus of the NIH research program is on “Mechanotransduction and Mechanical Stress induced Postoperative ileus” (POI). The goal is to
-
member of the Oncology Research Information Exchange Network (ORIEN) Robust clinical trials program with active translational therapeutics that include a clinical research unit, Phase 1 U01 grant and N01